The Boston-based biotech firm Gingko Bioworks Inc. recently announced a major partnership with Canadian cannabis company Cronos Group Inc. to work on what could be a groundbreaking and potentially epoch-shifting innovation in cannabis production. Taking a page straight out of Jurassic Park, Gingko wants to use plant DNA to genetically (re)produce cannabinoids directly, without growing the cannabis plants that naturally produce them.